SPOTLIGHT ON INDUSTRY: Keith Thomas, Brewlab Limited

Keith Thomas, Brewlab Limited What is your background and current job role? Brewlab is a leading provider of training and analysis services for the international brewing industry, based in purpose built premises on the banks of the river Wear in Sunderland. I am currently director of Brewlab Ltd, responsible for company developments and project management.  I am also a senior

Read more

SPOTLIGHT ON INDUSTRY: Charles Bavington, GlycoMar

Charles Bavington, GlycoMar What is your background and current job role? I am the founder of GlycoMar and a biochemist with over 15 years experience in marine biotechnology. I graduated of the University of Edinburgh and then completed my PhD at the same university, studying proteoglycan metabolism in cartilage. This was followed by postdoctoral research at Dunstaffnage marine lab studying invertebrate

Read more

Biosynthesis of the antibiotic nonribosomal peptide penicillin in baker’s yeast

Biosynthesis of the antibiotic nonribosomal peptide penicillin in baker’s yeast Fungi are a valuable source of enzymatic diversity and therapeutic natural products including antibiotics. Here we engineer the baker’s yeast Saccharomyces cerevisiae to produce and secrete the antibiotic penicillin, a beta-lactam nonribosomal peptide, by taking genes from a filamentous fungus and directing their efficient expression and subcellular localization. Using synthetic

Read more

Whole-cell biocatalysts by design

Whole-cell biocatalysts by design Whole-cell biocatalysts provide unique advantages and have been widely used for the efficient biosynthesis of value-added fine and bulk chemicals, as well as pharmaceutically active ingredients. What is more, advances in synthetic biology and metabolic engineering, together with the rapid development of molecular genetic tools, have brought about a renaissance of whole-cell biocatalysis. These rapid advancements

Read more

WE NEED TO TALK ABOUT GENE TECH: CBMNet Management Board Member Prof Susan Molyneux Hodgson

  CBMNet Management Board Member Professor Susan Molyneux Hodgson spoke at the Hay Litery festival last night in the session ‘We Need to talk about Gene Tech’. Why does public debate and policy treat the application of genetic technology differently when we are discussing medicine and food? Why is our concept of what is ‘natural’ so controversial and the idea of

Read more

CBMNet Proof-of-Concept and Vacation Scholarship projects awarded

CBMNet Proof-of-Concept and Vacation Scholarship projects awarded Following on from our latest Proof-of-Concept and Vacation Scholarship funding calls we are pleased to announce that we have funded 6 projects. Proof-of-Concept: Newcastle University and Ingenza – L-form technologies: a novel platform for therapeutic protein production. Many human proteins are used for the treatment of a wide variety of diseases and many more

Read more

Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli

Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli The exploitation of the CRISPR/Cas9 machinery coupled to lambda (λ) recombinase-mediated homologous recombination (recombineering) is becoming the method of choice for genome editing in E. coli. First proposed by Jiang and co-workers, the strategy has been subsequently fine-tuned by several authors who demonstrated, by using few

Read more

£25,000 Proof-of-Concept Available

£25,000 Proof-of-Concept Available As a result of our last Proof-of-Concept call, and some under-spend, we have £25,000 of PoC funding remaining (@80%fEC). Therefore, we are inviting applications from our members for a final PoC project. Details: To allow consortia to generate the preliminary information required to establish the feasibility of their proposed approaches, with the target of generating competitive bids to

Read more

CBMNet goes International

We are pleased to announce that we have successfully been awarded funding from the BBSRC to expand CBMNet activities across the globe! We are headed to New Zealand for a workshop aimed at ‘Exploiting Algae and marine biomass for Industrial Biotechnology and Bioenergy’ In August 2017, CBMNet and PHYCONET members are heading to the Cawthron Institute, Nelson, New Zealand. The workshop focuses

Read more
« Older Entries